Shanghai, China – 15 May, 2015 – Shanghai MicroPort Medical (Group) Co ("MicroPort") hosted 2015 Annual Distributor Conference on May 14 in its Shanghai headquarters to promote its products to nationwide distributors. About 400 distributors attended the meeting.

During the event, brief introductions of MicroPort's devices, such as PROFEMUR™ Classic Z Hip Stem, PROPHECY™ Pre-Operative Navigation System, Occluder, REPLY DR/D/VDR/SR Peacemaker, La Fenice® Insulin Pump, Firestone® Cervical Fusion Device, Castor Thoracic Branch Stent-Graft System, Columbus™ 3D EP Navigation System, Firehawk® Rapamycin Target Eluting Coronary Stent System, WILLIS® Intracranial Stent Graft System, and APOLLO Intracranial Stent System, were presented to people in attendance. These products cover a wide range of business segments including cardiovascular, orthopedic, electrophysiological, endovascular, neurovascular, surgical and diabetes care and endocrinal management.

In the meeting, MicroPort also gave out several awards to 20 of its distributors, including Partner of the Best Contribution of the Year, Partner of the Best Sincerity of the Year, Partner of the Best Diversification of the Year, and Gold Certified Partner of the Year, to appreciate their trust and confidence in MicroPort.

"With a rapidly increasing product offering and continuously expanding overseas markets, we believe that there are boundless opportunities in all of MicroPort's business segments," said Bo Peng, Chief Marketing Officer and Chairman of Greater China Executive Committee of MicroPort Scientific Corporation, "MicroPort will keep bringing more innovative products to patients and surgeons, and we are looking forward to seeing more distributors join us and build an even more successful future together."